CytoDyn issues 932,272 shares to two former executives for ~$0.5M severance

CytoDyn Inc.

Issued 932,272 shares of common stock to two former executive officers as severance payments.
Aggregate consideration approximately $0.5 million net of payroll deductions and withholding taxes.
Number of shares based on closing price on due dates; reliance on Section 4(a)(2) exemption.
Sales exceeded 1% of shares outstanding as of March 24, 2022, triggering Item 3.02 disclosure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.